| Kelly K Sinutko, CRNA | |
|
700 S Park St, Madison, WI 53715-1830 | |
| (608) 251-6100 | |
| (608) 258-5222 |
| Full Name | Kelly K Sinutko |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 8 Years |
| Location | 700 S Park St, Madison, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043758188 | NPI | - | NPPES |
| 1043758188 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 7531-033 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Health St Mary's Hospital - Madison | Madison, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dean Health Systems Inc | 7012827983 | 1068 |
News Archive
How do you fight a fungal infection that is becoming increasingly resistant to medicine? By starving it, found a team of University at Buffalo and Temple University researchers.
"The G20 agriculture ministers seem to agree: they're all for food security, as long as it doesn't cost anything," according to a post on the Center for Global Development's "Rethinking U.S. Foreign Assistance Blog."
The most common tick-borne disease in humans is Lyme borreliosis. Extensive field and laboratory tests have revealed that the Borrelia bacterium is present in a larger proportion of ticks than has been shown by earlier studies.
The Swedish biotech company Xbrane Bioscience and the San Diego based biotech company Vaxiion Therapeutics, Inc. have announced that they have reached a licensing arrangement granting Xbrane Bioscience rights to Vaxiion's proprietary protein production system – the Rhamex System™.
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
› Verified 5 days ago
| Entity Name | Dean Health Systems Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053358846 PECOS PAC ID: 7012827983 Enrollment ID: O20031105000584 |
News Archive
How do you fight a fungal infection that is becoming increasingly resistant to medicine? By starving it, found a team of University at Buffalo and Temple University researchers.
"The G20 agriculture ministers seem to agree: they're all for food security, as long as it doesn't cost anything," according to a post on the Center for Global Development's "Rethinking U.S. Foreign Assistance Blog."
The most common tick-borne disease in humans is Lyme borreliosis. Extensive field and laboratory tests have revealed that the Borrelia bacterium is present in a larger proportion of ticks than has been shown by earlier studies.
The Swedish biotech company Xbrane Bioscience and the San Diego based biotech company Vaxiion Therapeutics, Inc. have announced that they have reached a licensing arrangement granting Xbrane Bioscience rights to Vaxiion's proprietary protein production system – the Rhamex System™.
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelly K Sinutko, CRNA 700 S Park St, Madison, WI 53715-1830 Ph: (608) 251-6100 | Kelly K Sinutko, CRNA 700 S Park St, Madison, WI 53715-1830 Ph: (608) 251-6100 |
News Archive
How do you fight a fungal infection that is becoming increasingly resistant to medicine? By starving it, found a team of University at Buffalo and Temple University researchers.
"The G20 agriculture ministers seem to agree: they're all for food security, as long as it doesn't cost anything," according to a post on the Center for Global Development's "Rethinking U.S. Foreign Assistance Blog."
The most common tick-borne disease in humans is Lyme borreliosis. Extensive field and laboratory tests have revealed that the Borrelia bacterium is present in a larger proportion of ticks than has been shown by earlier studies.
The Swedish biotech company Xbrane Bioscience and the San Diego based biotech company Vaxiion Therapeutics, Inc. have announced that they have reached a licensing arrangement granting Xbrane Bioscience rights to Vaxiion's proprietary protein production system – the Rhamex System™.
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
› Verified 5 days ago
Douglas J Konkol, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 700 S Park St, St Marys Hospital Dean Medical Center, Madison, WI 53715 Phone: 608-258-6975 Fax: 608-258-5222 | |
Jennifer J Schildt, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 700 S Park St, Madison, WI 53715 Phone: 608-251-6100 Fax: 608-258-5222 | |
Alyssa Ct Tesar, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 700 S Park St, Madison, WI 53715 Phone: 608-251-6100 | |
Wilma K Gillis, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 7 Fuller Dr, Madison, WI 53704 Phone: 608-244-9322 | |
Rebecca Ann Konkol, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-8100 Fax: 608-263-0575 | |
Christopher P Nelson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 700 S Park St, Madison, WI 53715 Phone: 608-251-6100 Fax: 608-258-5222 |